Joseph Balthasar, PhD
Professor, Department of Pharmaceutical Sciences, and Director, Center for Protein Therapeutics
The Chu chair was established with a gift from loyal alumni David C.K. Chu, PhD ’75, and Jane Chu, MS ’75, MA ’74.
Balthasar is an internationally renowned researcher in protein therapeutics through the development of innovative mechanistic and physiological models to describe and predict protein disposition.
Balthasar’s work also incorporates mathematic modeling to discover better ways to treat diseases. “Our approach is really to be opportunistic,” says Balthasar. “We look for problems that our strategies can solve.”
The McGlynn chair was established with a gift from dedicated alumnae Margaret Hempling McGlynn, BS '82 and MBA '83.
McGlynn, a former President of Merck Vaccines, is the founder of the Hempling Foundation for Homocystinuria Research, which funds research for new therapies for patients afflicted with homocystinuria, and HCU (Homocystinuria) Network America, which provides advocacy and support for affected families.
McGlynn’s two sisters, Judy and Susie Hempling, both passed away from homocystinuria, a rare metabolic genetic disease, when they were children. It was the loss of her sisters that ultimately inspired McGlynn’s gift to UB, as well as her life’s work.
“I believe that the University at Buffalo can have a huge impact on patients in the rare disease community, particularly metabolic disease, in Western New York," McGlynn says. “I want the school and this position to take a leadership role in figuring out what the gaps are and to create educational modules across disciplines to deliver integrated care for these patients. This new endowed faculty position at UB will help harness the interdisciplinary nature of care that will deliver improved outcomes."